Ilona Đoric

Belgrade, SE, Serbia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Advancing Immunoassay Precision: A Novel Preanalytical Method for Enhancing Thyroglobulin Measurement in the Presence of Tg Antibodies.

Advancing Immunoassay Precision: A Novel Preanalytical Method for Enhancing Thyroglobulin Measurement in the Presence of Tg Antibodies.

Journal: International journal of molecular sciences

Published: October 10, 2024

Detecting thyrotropin receptor mRNA from peripheral blood of patients with differentiated thyroid cancer rules out non-aggressive cases.

Detecting thyrotropin receptor mRNA from peripheral blood of patients with differentiated thyroid cancer rules out non-aggressive cases.

Journal: Annals of clinical biochemistry

Published: January 09, 2024

Challenges and current advances in the methodology of thyroglobulin measurements.

Challenges and current advances in the methodology of thyroglobulin measurements.

Journal: Bioanalysis

Published: November 22, 2023

BRAFV600E, BANCR, miR-203a-3p and miR-204-3p in Risk Stratification of PTC Patients.

BRAFV600E, BANCR, miR-203a-3p and miR-204-3p in Risk Stratification of PTC Patients.

Journal: Biomedicines

Published: October 26, 2023

Expression of pY397-FAK and Its miR Regulators Drive Dedifferentiation in the Thyroid Neoplasia Spectrum.

Expression of pY397-FAK and Its miR Regulators Drive Dedifferentiation in the Thyroid Neoplasia Spectrum.

Journal: Cells

Published: May 17, 2023

MiR-203a-3p, miR-204-3p, miR-222-3p as useful diagnostic and prognostic tool for thyroid neoplasia spectrum.

MiR-203a-3p, miR-204-3p, miR-222-3p as useful diagnostic and prognostic tool for thyroid neoplasia spectrum.

Journal: Endocrine

Published: June 29, 2022

Predictive Significance of Two MMP-9 Promoter Polymorphisms and Acetylated c-Jun Transcription Factor for Papillary Thyroid Carcinoma Advancement.

Predictive Significance of Two MMP-9 Promoter Polymorphisms and Acetylated c-Jun Transcription Factor for Papillary Thyroid Carcinoma Advancement.

Journal: Diagnostics (Basel, Switzerland)

Published: May 26, 2022

Focal adhesion kinase splicing and protein activation in papillary thyroid carcinoma progression.

Focal adhesion kinase splicing and protein activation in papillary thyroid carcinoma progression.

Journal: Histochemistry and cell biology

Published: November 11, 2021

Elevated BANCR expression levels have different effects on papillary thyroid carcinoma progression depending on the presence of the BRAFV600E mutation.

Elevated BANCR expression levels have different effects on papillary thyroid carcinoma progression depending on the presence of the BRAFV600E mutation.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: March 19, 2020

High expression and localization of β-catenin and epidermal growth factor receptor identify high risk papillary thyroid carcinoma patients.

High expression and localization of β-catenin and epidermal growth factor receptor identify high risk papillary thyroid carcinoma patients.

Journal: Experimental and molecular pathology

Published: March 28, 2018

Overexpression of epidermal growth factor receptor and its downstream effector, focal adhesion kinase, correlates with papillary thyroid carcinoma progression.

Overexpression of epidermal growth factor receptor and its downstream effector, focal adhesion kinase, correlates with papillary thyroid carcinoma progression.

Journal: International journal of experimental pathology

Published: August 18, 2017

Showing 1-11 of 11

Last Updated: 09/26/2026